Article
Editing TINF2 as a potential therapeutic approach to restore telomere length in dyskeratosis congenita.
Blood - 11 Aug 2022
Choo Seunga, Lorbeer Franziska K, Regalado Samuel G, Short Sarah B, Wu Shannon, Rieser Gabrielle, Bertuch Alison A, Hockemeyer Dirk
Abstract excerpt
Mutations in the TINF2 gene, encoding the shelterin protein TIN2, cause telomere shortening and the inherited bone marrow (BM) failure syndrome dyskeratosis congenita (DC). A lack of suitable model systems limits the mechanistic understanding of telomere shortening in the stem cells and thus hinders the development of treatment options for BM failure. Here, we endogenously introduced TIN2-DC mutations in human...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
